
Cyrus Poonawalla
#999Cyrus Soli Poonawalla is an Indian billionaire businessman, and the chairman and managing director of the Cyrus Poonawalla Group, which includes the Serum Institute of India, an Indian biotech company which is the largest vaccine manufacturer in the world, and Poonawalla Fincorp, a leading NBFC in India. In 2022, he was ranked as the 4th richest person in India on Forbes India rich list with a net worth of $24.3 billion. He was ranked number 1 on the Hurun Global Healthcare Rich List 2022.
Biography & Background
xAI Grokipedia EnrichedCyrus Soli Poonawalla is an Indian billionaire businessman, and the chairman and managing director of the Cyrus Poonawalla Group, which includes the Serum Institute of India, an Indian biotech company which is the largest vaccine manufacturer in the world, and Poonawalla Fincorp, a leading NBFC in India. In 2022, he was ranked as the 4th richest person in India on Forbes India rich list with a net worth of $24.3 billion. He was ranked number 1 on the Hurun Global Healthcare Rich List 2022.
- Son of a horse breeder, Cyrus Poonawalla founded Serum Institute of India in 1966 and built it into the world's largest vaccine maker (by doses).
- Headquartered in Pune city, close to Mumbai, Serum produces over 1.5 billion doses annually of a range of vaccines, including for measles, polio and flu.
- Under his U.K.-educated son Adar, Serum's CEO, the company invested $800 million at the peak of the pandemic to build a new factory in Pune to make Covid-19 vaccines.
- Poonawalla's assets include a majority stake in listed financial services firm Poonawalla Fincorp as well as a stake in The Ritz-Carlton hotel in Pune.
- In 2023, his son Adar bought Aberconway House, a mansion in London's Mayfair, for 138 million pounds. In 2026, Adar bought an 18% stake in cricket team Rajasthan Royals for $300 million.
xAI Grokipedia Intelligence Dossier
Autonomous verified knowledge graph (grokipedia.com)
Cyrus Poonawalla is indexed on xAI Grokipedia with verified corporate filings, cross-referenced real-time wealth indices, and primary source citations.